Single Center Retrospective Cohort Study of Non-Valvular Atrial Fibrillation Patients in Treated with Direct Oral Anticoagulants

Single Center Retrospective Cohort Study of Non-Valvular Atrial Fibrillation Patients in Treated with Direct Oral Anticoagulants - Single Center Retrospective Cohort Study of Patients Treated with DOAC for Stroke Prevention in NVAF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025009

Enrollment

670

Registered

2016-11-27

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Valvular Atrial Fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had received a diagnosis of NVAF and been treated with Dabigatran, Rivaroxaban, or Apixaban

Exclusion criteria

Exclusion criteria: Patients who never visited the hospital after they were prescribed NOAC

Design outcomes

Primary

Measure	Time frame
Discontinuation of anticoagulant therapy	—

Secondary

Measure	Time frame
Ischemic stroke or systemic embolism, bleeding events and all-cause mortality	—

Countries

Japan

Contacts

Public ContactMasahiko Umei

NTT medical Center Tokyo Department of Cardiology

m-umei@umin.org03-3448-6111

Outcome results